Literature DB >> 20795743

Eucapsitrione, an anti-Mycobacterium tuberculosis anthraquinone derivative from the cultured freshwater cyanobacterium Eucapsis sp.

Megan Sturdy1, Aleksej Krunic, Sanghyun Cho, Scott Franzblau, Jimmy Orjala.   

Abstract

Eucapsitrione (1), an anthraquinone derivative with an indeno-anthracene-trione skeleton, was isolated from the cyanobacterium Eucapsis sp. (UTEX 1519) by bioassay-guided fractionation. The chemical structure was determined by analyzing MS and 1D and 2D NMR spectroscopic data. Eucapsitrione (1) showed anti-Mycobacterium tuberculosis activity in the microplate Alamar blue assay and low-oxygen-recovery assay with MIC values of 3.1 and 6.4 microM, respectively.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20795743      PMCID: PMC2972581          DOI: 10.1021/np100299v

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  11 in total

1.  Structural Interactions among Epilithic Cyanobacteria and Heterotrophic Microorganisms in Roman Hypogea.

Authors: 
Journal:  Microb Ecol       Date:  1999-10       Impact factor: 4.552

2.  New antibacterial metabolites from the cyanobacterium Nostoc commune(EAWAG 122b).

Authors:  B Jaki; J Heilmann; O Sticher
Journal:  J Nat Prod       Date:  2000-09       Impact factor: 4.050

Review 3.  Panning for chemical gold: marine bacteria as a source of new therapeutics.

Authors:  Philip G Williams
Journal:  Trends Biotechnol       Date:  2008-11-18       Impact factor: 19.536

4.  Antibiotic bisanthraquinones produced by a streptomycete isolated from a cyanobacterium associated with Ecteinascidia turbinata.

Authors:  Aaron M Socha; Dioscaris Garcia; Roberta Sheffer; David C Rowley
Journal:  J Nat Prod       Date:  2006-07       Impact factor: 4.050

5.  Systems biology of cyanobacterial secondary metabolite production and its role in drug discovery.

Authors:  Nishikant V Wase; Phillip C Wright
Journal:  Expert Opin Drug Discov       Date:  2008-08       Impact factor: 6.098

6.  Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.

Authors:  Sang Hyun Cho; Saradee Warit; Baojie Wan; Chang Hwa Hwang; Guido F Pauli; Scott G Franzblau
Journal:  Antimicrob Agents Chemother       Date:  2007-01-08       Impact factor: 5.191

7.  Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium.

Authors:  L Collins; S G Franzblau
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

8.  Antimycobacterial cycloartanes from Borrichia frutescens.

Authors:  C L Cantrell; T Lu; F R Fronczek; N H Fischer; L B Adams; S G Franzblau
Journal:  J Nat Prod       Date:  1996-12       Impact factor: 4.050

Review 9.  Bioactive natural products from marine cyanobacteria for drug discovery.

Authors:  Lik Tong Tan
Journal:  Phytochemistry       Date:  2007-03-02       Impact factor: 4.072

10.  Investigation of antimicrobial and protease-inhibitory activity from cultured cyanobacteria.

Authors:  George Chlipala; Shunyan Mo; Esperanza J Carcache de Blanco; Aiko Ito; Stanley Bazarek; Jimmy Orjala
Journal:  Pharm Biol       Date:  2009-01       Impact factor: 3.503

View more
  4 in total

1.  Elucidation of marine fungi derived anthraquinones as mycobacterial mycolic acid synthesis inhibitors: an in silico approach.

Authors:  Akanksha Sharma; M Hayatul Islam; Nida Fatima; Tarun K Upadhyay; M Kalim A Khan; Upendra N Dwivedi; Rolee Sharma
Journal:  Mol Biol Rep       Date:  2019-02-04       Impact factor: 2.316

2.  Reduction of Silver Ions by Cell Free Extracts of Westiellopsis sp.

Authors:  P T V Lakshmi; Devi Priyanka; A Annamalai
Journal:  Int J Biomater       Date:  2015-02-01

3.  Regiodefined synthesis of brominated hydroxyanthraquinones related to proisocrinins.

Authors:  Joyeeta Roy; Tanushree Mal; Supriti Jana; Dipakranjan Mal
Journal:  Beilstein J Org Chem       Date:  2016-03-16       Impact factor: 2.883

4.  Cyanobacterial metabolites as promising drug leads against the Mpro and PLpro of SARS-CoV-2: an in silico analysis.

Authors:  Devashan Naidoo; Ayan Roy; Pallab Kar; Taurai Mutanda; Akash Anandraj
Journal:  J Biomol Struct Dyn       Date:  2020-07-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.